TagOpioid Substitution

Prisons need better drug treatment programs to control infectious diseases


The Conversation, July 15, 2016 10.56am AEST Worldwide, around 30 million people enter and leave prison each year. Of these people, around 4.5 million have hepatitis C, almost 1 million have HIV and 1.5 million have hepatitis B infections. In many countries, prisons are underfunded and overcrowded, and injecting drug use is common. Those who enter prison uninfected are at risk of becoming...

Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes


Clin Infect Dis. 2016 Jun 25. pii: ciw416. [Epub ahead of print] Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis BACKGROUND: Human immunodeficiency virus (HIV)-infected people who inject drugs (PWID) frequently encounter barriers accessing and remaining on antiretroviral therapy (ART). Some studies have suggested that opioid...

To tackle hepatitis C, we need to close the justice gap


Croakey, Dec 22, 2015 Health Minister Sussan Ley’s announcement of PBS listing for new treatments for hepatitis C has been welcomed by Hepatitis NSW as “brilliant news”. Given the high rates of hepatitis C among people in prisons, it is significant that the Government has agreed to fund these medicines for prisoners. However, tackling hepatitis C will also require public health interventions such...

The health of Australia’s prisoners 2015


AIHW, released: 27 Nov 2015 The health of Australia’s prisoners 2015 is the fourth report produced by the Australian Institute of Health and Welfare on the health and wellbeing of prisoners. The report explores the conditions and diseases experienced by prisoners; compares, where possible, the health of prisoners to the general Australian community and provides valuable insight into the use of...

How patterns of injecting drug use evolve in a cohort of PWID


Australian Institute of Criminology, June 2015
This study examines some of the ways in which injecting drug use evolves over time in a cohort of People Who Inject Drugs. It shows shifts in the settings in which cohort members reported buying and using their drugs. These shifts have important implications for the harms experienced by PWID, and the wider community.
Read more here

Your sidebar area is currently empty. Hurry up and add some widgets.